Whole-blood transcriptomic response to whole-body hyperthermia in participants with major depressive disorder
Brain, Behavior, & Immunity - Health · 2026-07 · 54 · 101225
DOI: 10.1016/j.bbih.2026.101225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, & Immunity - Health, 2026-07. Verfasst von Tyler N Akonom und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Brain & Behavior Research Foundation, Institute for Mental Health Research, B. Braun-Stiftung.
Abstract (Originalsprache)
Depression is the leading cause of global disability according to the World Health Organization. Current pharmacologic interventions suffer from significant limitations and side effects, highlighting a need for novel therapeutic approaches. Whole-body hyperthermia (WBH) has been identified as a promising avenue of treatment of major depressive disorder (MDD); however, the mechanisms responsible for the antidepressant effects of WBH are not completely understood. In a previously published trial, we randomized adults with moderate to severe MDD (Hamilton Depression Rating Scale (HDRS) score >16) to one of two interventions (WBH or sham WBH). We collected whole blood 30 min post-intervention and followed participants for 6 weeks. In these analyses, we used a high-throughput RNA sequencing (RNA-seq) approach to compare the whole-blood transcriptomic response 30 min post-intervention. Differentially expressed gene (DEG) analysis with a Benjamini-Hochberg false discovery rate (FDR)-adjusted p-value (q-value) < 0.01 identified 17 upregulated DEGs including, as expected, multiple genes encoding heat-shock proteins belonging to the heat-shock protein (HSP) 70, HSP90, and HSP110 families, but also identified upregulated DEGs associated with immune response. Resulting log-fold changes and unadjusted p-values for all genes were used in Gene Set Enrichment Analysis (GSEA), which identified 88 enriched gene sets using a Benjamini-Hochberg FDR-adjusted p-value (q-value) of
Autor:innen und Institutionen
- Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.
- BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80309, USA.
- Sleep and Health Research Program, University of Arizona College of Medicine, Tucson, AZ 85724, USA.
- Osher Center for Integrative Health, University of California San Francisco, San Francisco, CA 94115, USA.
- Research Design Associates Inc, Yorktown Heights, NY 10598, USA.
- Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, WI 53719, USA.
Förderung
- Brain & Behavior Research Foundation
- Institute for Mental Health Research
- B. Braun-Stiftung
Zitieren
APA
Akonom, T. N., Allen, M. A., Begay, T. K., Mason, A. E., Cole, S. P., Raison, C. L., & Lowry, C. A. (2026). Whole-blood transcriptomic response to whole-body hyperthermia in participants with major depressive disorder. Brain, Behavior, & Immunity - Health, 54, 101225. https://doi.org/10.1016/j.bbih.2026.101225
Vancouver
Akonom TN, Allen MA, Begay TK, Mason AE, Cole SP, Raison CL, et al. Whole-blood transcriptomic response to whole-body hyperthermia in participants with major depressive disorder. Brain, Behavior, & Immunity - Health. 2026;54:101225. doi:10.1016/j.bbih.2026.101225
BibTeX
@article{Akonom2026,
author = {Akonom, Tyler N and Allen, Mary A and Begay, Tommy K and Mason, Ashley E and Cole, Steven P and Raison, Charles L and Lowry, Christopher A},
title = {Whole-blood transcriptomic response to whole-body hyperthermia in participants with major depressive disorder},
journal = {Brain, Behavior, & Immunity - Health},
year = {2026},
volume = {54},
pages = {101225},
doi = {10.1016/j.bbih.2026.101225}
}
EUVIMED